medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2020, Number S1

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (S1)

Obesity and contraception

Rosas-Balan A

Language: Spanish
References: 12
Page: 131-139
PDF size: 254.68 Kb.


ABSTRACT

Background: Obesity (BMI ≥ 30 kg/m2) is a systemic, chronic and multifactorial disease, that affects all age groups, of different ethnia and any social class.
Objective: Based on the available scientific evidence, to deepen the knowledge of the different conditions that are part of the concept of “obesity and contraception”.
Methodology: Primary sources were searched in PubMed, ScienceDirect and the Cochrane Library, using the keywords (MeSH): overweight and obesity, combined contraceptives, metabolic effects in overweight users of contraceptives. The most relevant articles were selected and assigned a level of evidence. The quality of the evidence and formulation of the recommendations exposed in different articles, according to the methodology established by the GRADE system, was considered to perform this study.
Conclusions: It is important that physicians provide family planning needs for obese patients, in order to prevent unplanned pregnancy and its possible obstetric complications. The use of contraceptives in overweight and obese women does not differ from that of normal weight. After analyzing the studies and adjusting them according to age, ethnicity, education and desire for pregnancy, it was reported the use of contraceptives in 28% in women with normal weight versus 25.2% in overweight women and 25.3-33% in women with obesity. Progestin-only contraceptives and intrauterine devices cause minimal metabolic effects and are effective in most obese women. Combined hormones are associated with an increased risk of thromboembolism in obese women; however, its prescription is justified if other contraceptive methods are not available.


REFERENCES

  1. Dávila-Torres J, et al. Panorama de la Obesidad en México. Rev Med Inst Mex Seguro Soc 2015;53(2):240-249. http://revistamedica.imss.gob.mx/editorial/index.php/ revista_medica/article/viewFile/21/54

  2. Dutton H, et al. Obesity in pregnancy optimizing outcomes for mom and baby. Med Clin N Am 2018;102:87-106. https://doi.org/10.1016/j.mcna.2017.08.008.

  3. Simmons KB, et al. Contraception and sexual health in obese women. Best Pract Res Clin Obstet Gynaecol 2015;29(4):466-478. https://doi.org/10.1016/j.bpobgyn. 2014.10.005.

  4. Jatlaoui TC, et al. Healthcare Provider Attitudes Regarding Contraception for Women with Obesity. J Womens Health (Larchmt) 2017;26(8):870-877. https://doi. org/10.1089/jwh.2016.5930.

  5. Mody SK, et al. Obesity and contraception. Clin Obstet Gynecol 2014;57(3):501-507. https://doi.org/10.1097/ GRF.0000000000000047.

  6. Simmons KB, Edelman AB. Hormonal contraception and obesity. Fertil Steril 2016;106(6):1282-1288. https://doi. org/10.1016/j.fertnstert.2016.07.1094.

  7. Merki-Feld GS, et al. European society of contraception statement on contraception in obese women. Eur J Contracept Reprod Health Care 2015;20(1):19-28. https://doi. org/10.3109/13625187.2014.960561.

  8. Jatlaoui TC, et al. Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review. Contraception 2016;94(6):605-611. https://doi.org/10.1016/j.contraception.2016.05.002.

  9. Maclean CC, et al. Postpartum care and contraception in obese women. Clin Obstet Gynecol 2016;59(1):204- 15. https://doi.org/10.1097/GRF.0000000000000176.

  10. Menke MN, et al. Contraception and Conception After Bariatric Surgery. Obstet Gynecol 2017;130(5):979-987. https://doi.org/10.1097/AOG.0000000000002323.

  11. Lindh I, et al. The long-term influence of combined oral contraceptives on body weight. Hum Reprod 2011;26(7):1917- 24. https://doi.org/10.1093/humrep/der094.

  12. Fischer MA. Implanon: A New Contraceptive Implant. J Obstet Gynecol Neonatal Nurs 2008;37(3):361-8. https:// doi.org/10.1111/j.1552-6909.2008.00247.x.




2020     |     www.medigraphic.com